Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 4 de 4
Filter
Add more filters










Database
Language
Publication year range
2.
J Clin Microbiol ; 57(3)2019 03.
Article in English | MEDLINE | ID: mdl-30602443

ABSTRACT

Mycoplasma genitalium is frequently associated with urogenital and rectal infections, with the number of cases of macrolide-resistant and quinolone-resistant M. genitalium infection continuing to increase. In this study, we examined the levels of resistance to these two common antibiotic treatments in geographically distinct locations in Queensland, Australia. Samples were screened for macrolide resistance-associated mutations using a commercially available kit (ResistancePlus MG; SpeeDx), and quinolone resistance-associated mutations were identified by PCR and DNA sequencing. Comparisons between antibiotic resistance mutations and location/gender were performed. The levels of M. genitalium macrolide resistance were high across both locations (62%). Quinolone resistance mutations were found in ∼10% of all samples, with a number of samples harboring mutations conferring resistance to both macrolides and quinolones. Quinolone resistance was higher in southeast Queensland than in north Queensland, and this was consistent in both males and females (P = 0.007). The M. genitalium isolates in rectal swab samples from males harbored high levels of macrolide (75.9%) and quinolone (19%) resistance, with 15.5% harboring resistance to both classes of antibiotics. Overall, the lowest observed level of resistance was to quinolones in females from north Queensland (1.6%). These data highlight the high levels of antibiotic resistance in M. genitalium isolates within Queensland and the challenges faced by sexually transmitted infection clinicians in managing these infections. The data do, however, show that the levels of antibiotic resistance may differ between populations within the same state, which has implications for clinical management and treatment guidelines. These findings also support the need for ongoing antibiotic resistance surveillance and tailored treatment.


Subject(s)
Anti-Bacterial Agents/pharmacology , Drug Resistance, Bacterial , Mycoplasma Infections/microbiology , Mycoplasma genitalium/isolation & purification , Sexually Transmitted Diseases, Bacterial/microbiology , Australia/epidemiology , Drug Resistance, Bacterial/genetics , Epidemiological Monitoring , Female , Humans , Macrolides/pharmacology , Male , Mutation , Mycoplasma Infections/epidemiology , Mycoplasma genitalium/genetics , Quinolines/pharmacology , Sex Factors , Sexually Transmitted Diseases, Bacterial/epidemiology
3.
Sci Rep ; 8(1): 15112, 2018 10 11.
Article in English | MEDLINE | ID: mdl-30310099

ABSTRACT

Neonates are exposed to microbes in utero and at birth, thereby establishing their microbiota (healthy microbial colonisers). Previously, we reported significant differences in the neonatal oral microbiota of breast-fed and formula-fed babies after first discovering a primal metabolic mechanism that occurs when breastmilk (containing the enzyme xanthine oxidase) and neonatal saliva (containing highly elevated concentrations of the substrates for xanthine oxidase: xanthine and hypoxanthine). The interaction of neonatal saliva and breast milk releases antibacterial compounds including hydrogen peroxide, and regulates the growth of bacteria. Using a novel in vitro experimental approach, the current study compared the effects of this unique metabolic pathway on a range of bacterial species and determined the period of time that microbial growth was affected. We demonstrated that microbial growth was inhibited predominately, immediately and for up to 24 hr following breastmilk and saliva mixing; however, some microorganisms were able to recover and continue to grow following exposure to these micromolar amounts of hydrogen peroxide. Interestingly, growth inhibition was independent of whether the organisms possessed a catalase enzyme. This study further confirms that this is one mechanism that contributes to the significant differences in the neonatal oral microbiota of breast-fed and formula-fed babies.


Subject(s)
Bacteria/growth & development , Microbiota , Milk, Human , Mouth/microbiology , Saliva , Adult , Female , Humans , Hydrogen Peroxide/pharmacology
4.
Sci Rep ; 6: 38309, 2016 12 06.
Article in English | MEDLINE | ID: mdl-27922070

ABSTRACT

In utero and upon delivery, neonates are exposed to a wide array of microorganisms from various sources, including maternal bacteria. Prior studies have proposed that the mode of feeding shapes the gut microbiota and, subsequently the child's health. However, the effect of the mode of feeding and its influence on the development of the neonatal oral microbiota in early infancy has not yet been reported. The aim of this study was to compare the oral microbiota of healthy infants that were exclusively breast-fed or formula-fed using 16S-rRNA gene sequencing. We demonstrated that the oral bacterial communities were dominated by the phylum Firmicutes, in both groups. There was a higher prevalence of the phylum Bacteroidetes in the mouths of formula-fed infants than in breast-fed infants (p = 0.01), but in contrast Actinobacteria were more prevalent in breast-fed babies; Proteobacteria was more prevalent in saliva of breast-fed babies than in formula-fed neonates (p = 0.04). We also found evidence suggesting that the oral microbiota composition changed over time, particularly Streptococcus species, which had an increasing trend between 4-8 weeks in both groups. This study findings confirmed that the mode of feeding influences the development of oral microbiota, and this may have implications for long-term human health.


Subject(s)
Breast Feeding , Infant Formula/microbiology , Microbiota/genetics , Milk, Human/microbiology , Mouth/microbiology , Saliva/microbiology , Actinobacteria/classification , Actinobacteria/genetics , Actinobacteria/isolation & purification , Bacteroidetes/classification , Bacteroidetes/genetics , Bacteroidetes/isolation & purification , Female , Firmicutes/classification , Firmicutes/genetics , Firmicutes/isolation & purification , Gestational Age , High-Throughput Nucleotide Sequencing , Humans , Infant , Infant, Newborn , Male , Phylogeny , Proteobacteria/classification , Proteobacteria/genetics , Proteobacteria/isolation & purification , RNA, Ribosomal, 16S/genetics , Streptococcus/classification , Streptococcus/genetics , Streptococcus/isolation & purification
SELECTION OF CITATIONS
SEARCH DETAIL
...